PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 117 filers reported holding PROVENTION BIO INC in Q3 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $3,982,737 | +22.9% | 213,116 | -30.5% | 0.04% | +40.7% |
Q4 2022 | $3,240,191 | +906.3% | 306,546 | +702.3% | 0.03% | +800.0% |
Q2 2021 | $322,000 | -71.7% | 38,208 | -64.8% | 0.00% | -78.6% |
Q1 2021 | $1,137,000 | +303.2% | 108,441 | +365.4% | 0.01% | +40.0% |
Q2 2019 | $282,000 | – | 23,300 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DG Capital Management, LLC | 417,092 | $5,351,000 | 3.22% |
Johnson & Johnson Innovation - JJDC, Inc. | 574,973 | $7,377,000 | 1.48% |
Soleus Capital Management, L.P. | 139,418 | $1,789,000 | 0.95% |
683 Capital Management, LLC | 859,314 | $11,025,000 | 0.81% |
Perceptive Advisors | 4,265,711 | $54,729,000 | 0.80% |
GILDER GAGNON HOWE & CO LLC | 2,151,402 | $27,602,000 | 0.17% |
Virtus ETF Advisers LLC | 21,485 | $276,000 | 0.14% |
RICE HALL JAMES & ASSOCIATES, LLC | 230,873 | $2,962,000 | 0.12% |
Windsor Creek Advisors, LLC | 28,492 | $366,000 | 0.10% |
Newbridge Financial Services Group, Inc. | 6,500 | $83,000 | 0.08% |